Top compounds associated with response to FADD


Feature Type Standardized
Nominal ANOVA
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.11 0.002
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.1 0.002
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.095 0.004
mRNA PD-0332991 GDSC1000 pan-cancer AAC 0.11 0.004
mRNA masitinib CTRPv2 pan-cancer AAC -0.12 0.005
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.11 0.005
mRNA SR8278 CTRPv2 pan-cancer AAC 0.39 0.005
mRNA FK866 GDSC1000 pan-cancer AAC -0.091 0.005
Download CSV